This is a community-generated profile. If you would like to claim it, please .
Reata Pharmaceuticals Funding
$0
55 rounds
Reata Pharmaceuticals is active in the following markets / industries: biotechnology. The company has secured funding across 5 rounds and is valued at $0. Their most recent funding was raised on June 1, 2016.
Funding Rounds
IPO
$60900000U
$300000000U
$78000000UnknownJul 2010
U
$2000000U
$17000000Investors of Reata Pharmaceuticals
Gerald Dennig
Founder Bassline • Worked at @Goldman Sachs. Built complex enterprise solutions for UBS & Goldman over two decades. Exited two intelligent decision platforms.
Brett Young
Startech Early Ventures
University of Texas
CPMG
Global commercial banking fueling today’s innovators, entrepreneurs and investors
Founder/Managing Partner of Hunt Technology Ventures, L.P. / Early stage investor backing relentless founders with disruptive ideas.
Novo A/S
Rounds
U